ShockWave Medical

$129.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.51 (-1.15%) Today

$0.00 (0.00%) As of 10:14 AM UTC after-hours

Why Robinhood?

You can buy or sell SWAV and other stocks, options, and ETFs commission-free!

About SWAV

Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA. The listed name for SWAV is ShockWave Medical, Inc. Common Stock.

CEO

Douglas Evan Godshall

Employees

284

Headquarters

Santa Clara, California

Founded

2009

Market Cap

4.48B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

493.21K

High Today

$131.21

Low Today

$129.05

Open Price

$130.50

Volume

230.42K

52 Week High

$143.79

52 Week Low

$22.01

Collections

Analyst Ratings

50%

of 6 ratings

Buy

50%

Hold

50%

Sell

SWAV Earnings

-$0.62

-$0.41

-$0.21

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Feb 17, After Hours